Moreover, in vitro studies in hepatoma cell lines indicated that the anti-tumor impact of decorin is probably associated with its interaction with surface cell receptors, like epidermal growth factor receptor (EGFR), insulin-like growth factor 1-receptor (IGF-1R), and other major tyrosine kinase receptors (TRKs). This evidence concerns the gene DCN and hepatocellular carcinoma.